Resonant Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
ATO
Resonant Capital Advisors's MRK Position: Q2 2026 in Review
Resonant Capital Advisors increased its Merck (MRK) stake by 1.7% in Q2 2026, buying an estimated $61K and bringing the position to 31,697 shares worth $4.1M. The position accounts for 0.2% of the portfolio, ranked #86.
Resonant Capital Advisors first reported a position in MRK in Q4 2019 and has held it in 22 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Resonant Capital Advisors held 31,697 shares of Merck worth $4.1M as of Q2 2026.
- Resonant Capital Advisors bought 521 Merck shares in Q2 2026, an estimated $61K.
- Merck made up 0.2% of Resonant Capital Advisors's portfolio in Q2 2026, its #86 holding.
- Resonant Capital Advisors first reported a position in Merck in Q4 2019 and has held it in 22 quarters since.
- 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.